High Quality Decapeptide-12 Growth Hormone Peptides Lyophilized Hyperpigmentation Powder

Basic information:

INCI name: Decapeptide-12
Decapeptide-12 Cas No: 6918-09-8
Decapeptide-12 Purity: 95%
Decapeptide-12 Grade: cosmetic
COA and MSDS: available for your reference
Decapeptide-12 Solubility: slightly soluble/soluble in water
Decapeptide-12 Stability: stable
Risk: irritation, low irritation to skin, eye
Decapeptide-12 Ph value: 6.0-7.5
Decapeptide-12 Additive: 100 PPM
Source: synthetic
Capacity: 500g per month
Appearance: white to pale yellow powder

Product Description:

Decapeptide-12 reduces the appearance of hyperpigmentation-age spots, sun spots, uneven skin tone and photo damage-without the typical side effects of other brighteners like irritation and redness. Plus, soothing antioxidants like licorice root also ease sensitive skin.

The rapidly growing field of targeted tumor therapy often utilizes an antibody, sometimes tagged with a tumor-ablating material such as radioisotope, directed against a specific molecule. This report describes the discovery of nine novel decapeptides which can be radioactively labeled, bind to, and deliver P to colon cancer cells. The decapeptides vary from one another by one to three amino acids and demonstrate vastly different binding abilities. The most avidly binding decapeptide can permanently deliver very high levels of radioisotope to the adenocarcinoma cancer cell lines at an efficiency 35 to 150 times greater than to a variety of other cell types, including cell lines derived from other types of cancer or from normal tissue. This experimental approach represents a new example of a strategy, termed peptide binding therapy, for the potential treatment of colorectal and other adenocarcinomas.

Usage:

The treatment of postinflammatory hyperpigmentation (PIH) tends to be a difficult and prolonged process that often takes 6-12 months to achieve the desired results of depigmentation. Each of these treatment options potentially improves epidermal hypermelanosis, but none is proven effective for dermal hypermelanosis. Daily use of a broad-spectrum sunscreen (sun protection factor [SPF] 15 or greater) is an essential part of any therapeutic regimen.